All News

In case you missed it, this week we had news about illegal online GLP-1 sales, pharmacy deserts, innovative medication cooling technologies, and more.

Check out this recap of articles published on our sister sites during the past week.

Check out a recap of important pharmacy news you might have missed this week, dispensed in small doses.

Researchers analyzed data from every county in the US and aimed to address the association between high social vulnerability and pharmacy deserts.

Check out important updates from the FDA for the week of August 19.

Dana Krug, Senior Vice President of Cold Chain Fulfillment at Phononic, discussed the importance of cooling medications in the rising heat of the summer months.

Recent research on diabetes has examined its bidirectional relationship with mental health, the significant increase in prevalence over the last decade, and how both diet and exercise can help prevent type 2 diabetes.

Access inequities are preventing the US-affiliated Pacific Island (USAPI) jurisdictions from meeting the WHO 2030 goal of 90% human papillomavirus (HPV) vaccination series completion coverage.

Dana Krug, Senior Vice President of Cold Chain Fulfillment at Phononic, discussed the role his company’s technology plays in the pharmaceutical industry.

A detailed report of study findings will be published in a peer-reviewed journal and presented at ObesityWeek 2024.

Timothy Mackey, MAS, PhD, discusses a study that sought to determine the risk of sourcing semaglutide from online platforms.

Research experts at the Brookings Institution in Washington, D.C., analyzed the savings estimates provided by CMS for its drug price negotiations and compared them with the institution’s own estimates.

FDA approval of Amneal Pharmaceuticals' propofol injectable emulsion single-dose vials aims to address the drug’s history of chronic supply issues.

Timothy Mackey, MAS, PhD, discusses the dangers associated with sourcing GLP-1s from illegal online pharmacies and the key role pharmacists play in warning patients.

The approval of apremilast to treat plaque psoriasis in children and adolescents aged 6 years and older was based on data from the phase 3 SPROUT trial.

Final approval of the therapy may occur after expiration of the 3-year regulatory exclusivity for Tyvaso DPI on May 23, 2025.

The American Pharmacists Association is dedicating further time and resources to its ongoing fight for federal PBM reform.

Focus group participants were receptive to using eHealth tools, but noted several barriers such as cost and availability.

Participants were asked to rate their level of concern on 26 health topics.

In case you missed it, this week we had news about digital therapeutics for depression, bracing for fall allergies, at-home tests for sexually transmitted infections, and more.

Check out this recap of articles published on our sister sites during the past week.

Check out a recap of important pharmacy news you might have missed this week, dispensed in small doses.

First To Know Syphilis Tests are expected to be available at major national retailers and online in late 2024.

Tom DePietro, PharmD, owner of DePietro’s Pharmacy in Dunmore, Pennsylvania, discussed his experience as an independent pharmacy owner working under the thumb of pharmacy benefit managers.

Check out important updates from the FDA for the week of August 12.

The partnership’s revolutionary new product is set to premiere at the National Association of Chain Drug Stores’ Total Store Expo in Boston, Massachusetts, kicking off on August 17, 2024.

Community pharmacies in counties with high racialized economic segregation had higher odds of restricting buprenorphine.

A CDC report called for “increased efforts” to ensure parents can obtain all recommended vaccines for their eligible children and realize the full potential of the VFC program.